Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer

Brachytherapy

Volumn 11, Issue 3, 2012, Pages 176-180

  Beriwal, Sushil ^a   Rwigema, Jean Claude M ^a   Higgins, Emma ^a   Kim, Hayeon ^a   Houser, Chris ^a   Sukumvanich, Paniti ^a   Olawaiye, Alexander ^a   Richard, Scott ^a   Kelley, Joseph L ^a   Edwards, Robert P ^a   Krivak, Thomas C ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

3D HDR; High dose rate; Interstitial brachytherapy; Vaginal cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RECTUM; SIGMOID; SURVIVAL RATE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TREATMENT RESPONSE; VAGINA CANCER; VAGINAL INJURY; VAGINAL ULCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; VAGINAL NEOPLASMS;

EID: 84859774718     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.05.005     Document Type: Article

References (34)

1. American Cancer Society. Available at: Accessed September 10, 2010. http://www.cancer.org/Cancer/VaginalCancer/DetailedGuide/.
2. Aalders J.G., Abeler V., Kolstad P. Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol 1984, 17:85-103.
3. Brown J.M., Dockerty M.B., Symmonds R.E., et al. Vaginal recurrence of endometrial carcinoma. Am J Obstet Gynecol 1968, 100:544-549.
4. Greene F.L., Page D.L., Fleming I.D. Gynecologic sites: vagina. AJCC cancer staging manual 2002, 255-258. Springer, New York, NY. 6th ed. F.L. Greene, D.L. Page, I.D. Fleming (Eds.).
5. Kirkbrid P., Fyles A., Simm J., et al. In-situ and invasive carcinoma of the vagina 1974-1989-Results of treatment and factors influencing outcome. Int J Radiat Oncol Biol Phys 1992, 24:S257.
6. Curran W., Whittington J.R., Peters A.J., et al. Vaginal recurrences of endometrial carcinoma: The prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 1988, 15:803-808.
7. Dancuar F., Delcos L., Wharton J.T., et al. Primary squamous cell carcinoma of the vagina treated by radiotherapy: A failure analysis-The M.D. Anderson Hospital experience 1955-1982. Int J Radiat Oncol Biol Phys 1988, 14:745-749.
8. Frank S.J., Jhingran A., Levenback C., et al. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 2005, 62:138-147.
9. Brown J.J., Gutierrez E.D., Lee J.K. MR appearance of the normal and abnormal vagina after hysterectomy. AJR Am J Roentgenol 1992, 158:95-99.
10. Chyle V., Zagars G.K., Wheeler J.A., et al. Definite radiotherapy for carcinoma of the vagina: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1996, 35:891-905.
11. Hasbini C., Haie-Meder C., Morice P., et al. Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas. Radiother Oncol 2002, 65:23-28.
12. Nag S., Erickson B., Parikh S., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000, 48:779-790.
13. Orton C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001, 49:183-189.
14. Tewari K., Cauccini F., Brewster W.R., et al. Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. Gynecol Oncol 1999, 74:416-422.
15. Perez C.A., Camel H.M., Galakatos A., et al. Definitive irradiation in carcinoma of the vagina: Long-term evaluation of results. Int J Radiat Oncol Biol Phys 1998, 15:1283-1290.
16. Nag S., Yacoub S., Copeland L.J., et al. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. Int J Radiat Oncol Biol Phys 2002, 54:1153-1159.
17. Beriwal S., Bhatnagar A., Heron D.E., et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 2006, 5:218-222.
18. Beriwal S., Heron D.E., Mogus R., et al. High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. Radiat Oncol 2008, 3:7.
19. Meertens H., Borger J., Steggerda M., et al. Evaluation and optimization on interstitial brachytherapy dose distributions. Brachytherapy from radium to optimization 1994, 300-306. Nucletron International B.V., Veenendaal, The Netherlands. R.F. Mould, J.J. Battermann, A.A. Martinez (Eds.).
20. Viswanathan A.N., Cormack R., Holloway C.L., et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 2006, 66:91-99.
21. Branson A.N., Dunn P., Kam K.C., et al. A device for interstitial therapy of low pelvic tumors-The Hammersmith perineal hedgehog. Br J Radiol 1985, 58:537-542.
22. Martinez A., Cox R.S., Edmunson G.K. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecological malignancies. Int J Radiat Oncol Biol Phys 1984, 10:297-305.
23. Charra C., Roy P., Coquard R. Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1998, 40:421-426.
24. Nag S., Erickson B., Parikh S., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000, 48:779-790.
25. Kushner D.M., Fleming P.A., Kennedy A.W., et al. High dose rate (192)Ir afterloading brachytherapy for cancer of the vagina. Br J Radiol 2003, 76:719-725.
26. Lieskovsky Y.E., Demanes D. Combination high-dose rate brachytherapy and external beam radiation therapy for the treatment of primary vaginal cancer: 5-year results. Int J Radiat Oncol Biol Phys 2004, 60:S308.
27. Kim H., Beriwal S., Houser C., et al. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: Is point a-based dose prescription still valid in image-guided brachytherapy?. Med Dosim 2011, 36:166-170.
28. Pötter R., Dimopoulos J., Bachtiary B., et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol 2006, 79:80-86.
29. Holloway C.L., Racine M.L., Cormack R.A., et al. Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. Radiother Oncol 2009, 93:307-310.
30. Viswanathan A.N., Dimopoulos J., Kirisits C., et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007, 68:491-498.
31. Baltas D., Kolotas C., Geramani K., et al. A conformality index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998, 40:515-524.
32. Koltas C., Baltas D., Zamboglou N. CT-based interstitial HDR brachytherapy. Strahlenther Onkol 1999, 175:419-427.
33. Major T., Polgar C., Fodor J., et al. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems. Radiother Oncol 2002, 62:103-111.
34. Eisbruch A., Johnston C.M., Martel M.K., et al. Customized gynecologic interstitial implants: CT-based planning, dose evaluation, and optimization aided by laparotomy. Int J Radiat Oncol Biol Phys 1998, 40:1087-1093.